Impact of HIPEC introduction in cytoreduction for ovarian cancer of ovarian origin: a real-world population study

被引：0
|
作者：
Mendez, Blanca Valenzuela [1 ]
Quenet, Francois [1 ]
Thezenas, Simon [1 ]
Carrere, Sebastien [1 ]
Maurregot, Anne [1 ]
Sgarbura, Olivia [1 ]
Colombo, Pierre-Emmanuel [1 ]
机构：
[1] Canc Inst Montpellier, Montpellier, France
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_1期
关键词：
D O I：
10.1136/ijgc-2024-ESGO.831
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1325
引用
收藏
页码：A423 / A424
页数：2
相关论文
共 50 条
  • [21] Misdiagnosis of appendiceal neoplasms as ovarian tumors: Impact of prior gynecologic surgery on definitive cytoreduction and HIPEC
    Garland-Kledzik, Mary
    Maithel, Shelley
    Jafari, Mehraneh D.
    Dehkordi-Vakil, Farideh
    Chaudhry, Haris
    Dinicu, Andreea
    Chang, Irene
    Krasnoff, Chloe
    Gambhir, Sahil
    Sheehan, Brian
    Pigazzi, Alessio
    EJSO, 2022, 48 (02): : 449 - 454
  • [22] How to start niraparib in real-world Asian ovarian cancer patients?
    Hong, Sook-Hee
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (02)
  • [23] Disparities in clinical trial participation in ovarian cancer: A real-world analysis
    Smith, Anna Jo Bodurtha
    Alvarez, Rafael
    Heintz, Jonathan
    Simpkins, Fiona
    Ko, Emily M.
    GYNECOLOGIC ONCOLOGY, 2023, 175 : 25 - 31
  • [24] Real-World Efficacy of Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer
    Hung, Jo-Ni
    Hsu, Shih-Tien
    Sun, Lou
    Hwang, Sheau-Feng
    Liu, Chih-Ku
    Shih, Yu-Hsiang
    Chen, Ming-Jer
    Wang, Jun-Sing
    Lu, Chien-Hsing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in Canada
    Guan, Qi
    Aktar, Suriya J.
    Pataky, Reka E.
    Stephen, Mariet Mathew
    Marques, Maud
    Gambaro, Karen
    Rachedi, Kahina
    Forster, Katharina
    Strub, Samara
    Stock, David
    de Leseleuc, Louis
    Cheung, Winson Y.
    Peacock, Stuart
    Farrer, Christie
    Gavura, Scott
    Tadrous, Mina
    Grant, Robert C.
    Chan, Kelvin K. W.
    CURRENT ONCOLOGY, 2024, 31 (06) : 3591 - 3602
  • [26] Incidental findings of borderline ovarian tumor or ovarian cancer - real-world data on surgical and oncological outcomes
    Joder, Carmen
    Smaadahl-Wey, Celine
    Zumwald, Lara
    Saner, Flurina
    Rauh, Claudia
    Hofer, Seline
    Wampfler, Julian
    Schlootz, Saskia
    Rau, Tilman
    Christe, Lucine
    Solass, Wiebke
    Imboden, Sara
    Mueller, Michael David
    Siegenthaler, Franziska
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Impact of lymphadenectomy rates in the quality assurance program in early ovarian cancer of the AGO Study Group - Real-world observations
    Wimberger, Pauline
    Pfisterer, Jacobus
    du Bois, Andreas
    Hilpert, Felix
    Kerkmann, Markus
    Sehouli, Jalid
    Mahner, Sven
    de Gregorio, Nikolaus
    Hanker, Lars
    Heitz, Florian
    Marme, Frederik
    Woelber, Linn
    Holtmann, Laura
    Elser, Gabriele
    Harter, Philipp
    EJSO, 2025, 51 (06):
  • [28] Treatment of peritoneal carcinornatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Robella, M.
    Vaira, M.
    Marsanic, P.
    Mellano, A.
    Borsano, A.
    Cinquegrana, A.
    Sottile, A.
    De Simone, M.
    MINERVA CHIRURGICA, 2014, 69 (01) : 27 - 35
  • [29] The impact of BMI on interval cytoreduction and survival for advanced ovarian cancer
    Othieno, Alisha
    McNamara, Blair
    Chapman, Jocelyn
    GYNECOLOGIC ONCOLOGY, 2022, 164 (01) : E29 - E30
  • [30] A real-world study on characteristics, treatments and outcomes in US patients with advanced stage ovarian cancer
    Beachler, Daniel C.
    Lamy, Francois-Xavier
    Russo, Leo
    Taylor, Devon H.
    Dinh, Jade
    Yin, Ruihua
    Jamal-Allial, Aziza
    Dychter, Samuel
    Lanes, Stephan
    Verpillat, Patrice
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
12345